COVID-19 vaccines that reduce symptoms but do not block infection need higher coverage and faster rollout to achieve population impact
David A. Swan, Chloe Bracis, Holly Janes, Mia Moore, Laura Matrajt, Daniel B. Reeves, Eileen Burns, Deborah Donnell, Myron S. Cohen, Joshua T. Schiffer, Dobromir Dimitrov
doi: https://doi.org/10.1101/2020.12.13.20248142
David A. Swan
1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center; Seattle, WA, USA
Chloe Bracis
2Université Grenoble Alpes, TIMC-IMAG / BCM, 38000, Grenoble, France
Holly Janes
1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center; Seattle, WA, USA
Mia Moore
1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center; Seattle, WA, USA
Laura Matrajt
1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center; Seattle, WA, USA
Daniel B. Reeves
1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center; Seattle, WA, USA
Eileen Burns
3Independent Researcher, Seattle, WA, USA
Deborah Donnell
1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center; Seattle, WA, USA
4Department of Global Health, University of Washington, Seattle, WA USA
Myron S. Cohen
5Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC USA
Joshua T. Schiffer
1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center; Seattle, WA, USA
6Clinical Research Division, Fred Hutchinson Cancer Research Center; Seattle, WA, USA
7Department of Medicine, University of Washington, Seattle, WA, USA
Dobromir Dimitrov
1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center; Seattle, WA, USA
8Department of Applied Mathematics, University of Washington, Seattle, WA, USA
Data Availability
All data and code used for analysis are available upon request from the corresponding author
Posted December 14, 2020.
COVID-19 vaccines that reduce symptoms but do not block infection need higher coverage and faster rollout to achieve population impact
David A. Swan, Chloe Bracis, Holly Janes, Mia Moore, Laura Matrajt, Daniel B. Reeves, Eileen Burns, Deborah Donnell, Myron S. Cohen, Joshua T. Schiffer, Dobromir Dimitrov
medRxiv 2020.12.13.20248142; doi: https://doi.org/10.1101/2020.12.13.20248142
COVID-19 vaccines that reduce symptoms but do not block infection need higher coverage and faster rollout to achieve population impact
David A. Swan, Chloe Bracis, Holly Janes, Mia Moore, Laura Matrajt, Daniel B. Reeves, Eileen Burns, Deborah Donnell, Myron S. Cohen, Joshua T. Schiffer, Dobromir Dimitrov
medRxiv 2020.12.13.20248142; doi: https://doi.org/10.1101/2020.12.13.20248142
Subject Area
Subject Areas
- Addiction Medicine (395)
- Allergy and Immunology (708)
- Anesthesia (199)
- Cardiovascular Medicine (2907)
- Dermatology (249)
- Emergency Medicine (436)
- Epidemiology (12676)
- Forensic Medicine (10)
- Gastroenterology (823)
- Genetic and Genomic Medicine (4532)
- Geriatric Medicine (412)
- Health Economics (723)
- Health Informatics (2895)
- Health Policy (1066)
- Hematology (382)
- HIV/AIDS (918)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4297)
- Nursing (233)
- Nutrition (631)
- Oncology (2249)
- Ophthalmology (639)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (275)
- Palliative Medicine (83)
- Pathology (493)
- Pediatrics (1192)
- Primary Care Research (491)
- Public and Global Health (6879)
- Radiology and Imaging (1515)
- Respiratory Medicine (912)
- Rheumatology (433)
- Sports Medicine (381)
- Surgery (481)
- Toxicology (60)
- Transplantation (208)
- Urology (178)